These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 21157037)

  • 21. Oligoclonality and innate-like features in the TCR repertoire of type II NKT cells reactive to a beta-linked self-glycolipid.
    Arrenberg P; Halder R; Dai Y; Maricic I; Kumar V
    Proc Natl Acad Sci U S A; 2010 Jun; 107(24):10984-9. PubMed ID: 20534460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen.
    Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A
    J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of novel glycolipid ligands activating a sulfatide-reactive, CD1d-restricted, type II natural killer T lymphocyte.
    Rhost S; Löfbom L; Rynmark BM; Pei B; Månsson JE; Teneberg S; Blomqvist M; Cardell SL
    Eur J Immunol; 2012 Nov; 42(11):2851-60. PubMed ID: 22777932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early activation of invariant natural killer T cells in a rheumatoid arthritis model and application to disease treatment.
    Miellot-Gafsou A; Biton J; Bourgeois E; Herbelin A; Boissier MC; Bessis N
    Immunology; 2010 Jun; 130(2):296-306. PubMed ID: 20113367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human invariant V alpha 24-J alpha Q TCR supports the development of CD1d-dependent NK1.1+ and NK1.1- T cells in transgenic mice.
    Capone M; Cantarella D; Schümann J; Naidenko OV; Garavaglia C; Beermann F; Kronenberg M; Dellabona P; MacDonald HR; Casorati G
    J Immunol; 2003 Mar; 170(5):2390-8. PubMed ID: 12594262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Invariant NKT cells regulate experimental autoimmune encephalomyelitis and infiltrate the central nervous system in a CD1d-independent manner.
    Mars LT; Gautron AS; Novak J; Beaudoin L; Diana J; Liblau RS; Lehuen A
    J Immunol; 2008 Aug; 181(4):2321-9. PubMed ID: 18684921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of immune responses by CD1d-restricted natural killer T cells.
    Van Kaer L
    Immunol Res; 2004; 30(2):139-53. PubMed ID: 15477656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Invariant natural killer T cells stimulated with cholesteryl glycosides modulate immune responses in allergy and delayed-type hypersensitivity.
    Shimamura M; Kamijo SI; Illarionov P
    Eur J Immunol; 2019 Feb; 49(2):348-350. PubMed ID: 30549010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural basis of NKT cell inhibition using the T-cell receptor-blocking anti-CD1d antibody 1B1.
    Ying G; Wang J; Mallevaey T; Van Calenbergh S; Zajonc DM
    J Biol Chem; 2019 Aug; 294(35):12947-12956. PubMed ID: 31296659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A molecular basis for NKT cell recognition of CD1d-self-antigen.
    Mallevaey T; Clarke AJ; Scott-Browne JP; Young MH; Roisman LC; Pellicci DG; Patel O; Vivian JP; Matsuda JL; McCluskey J; Godfrey DI; Marrack P; Rossjohn J; Gapin L
    Immunity; 2011 Mar; 34(3):315-26. PubMed ID: 21376640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Type I IFN-producing CD4 Valpha14i NKT cells facilitate priming of IL-10-producing CD8 T cells by hepatocytes.
    Wahl C; Bochtler P; Schirmbeck R; Reimann J
    J Immunol; 2007 Feb; 178(4):2083-93. PubMed ID: 17277112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of intracellular trafficking of CD1d on the formation of TCR repertoire of NKT cells.
    Shin JH; Park SH
    BMB Rep; 2014 May; 47(5):241-8. PubMed ID: 24755556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD1d-dependent natural killer T cells attenuate angiotensin II-induced cardiac remodelling via IL-10 signalling in mice.
    Wang HX; Li WJ; Hou CL; Lai S; Zhang YL; Tian C; Yang H; Du J; Li HH
    Cardiovasc Res; 2019 Jan; 115(1):83-93. PubMed ID: 29939225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distinct CD1d docking strategies exhibited by diverse Type II NKT cell receptors.
    Almeida CF; Sundararaj S; Le Nours J; Praveena T; Cao B; Burugupalli S; Smith DGM; Patel O; Brigl M; Pellicci DG; Williams SJ; Uldrich AP; Godfrey DI; Rossjohn J
    Nat Commun; 2019 Nov; 10(1):5242. PubMed ID: 31748533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells.
    Eberl G; Lees R; Smiley ST; Taniguchi M; Grusby MJ; MacDonald HR
    J Immunol; 1999 Jun; 162(11):6410-9. PubMed ID: 10352254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carbohydrate specificity of the recognition of diverse glycolipids by natural killer T cells.
    Zajonc DM; Kronenberg M
    Immunol Rev; 2009 Jul; 230(1):188-200. PubMed ID: 19594637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TCR Valpha14 natural killer T cells function as effector T cells in mice with collagen-induced arthritis.
    Ohnishi Y; Tsutsumi A; Goto D; Itoh S; Matsumoto I; Taniguchi M; Sumida T
    Clin Exp Immunol; 2005 Jul; 141(1):47-53. PubMed ID: 15958069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The sequential activity of Gata3 and Thpok is required for the differentiation of CD1d-restricted CD4+ NKT cells.
    Wang L; Carr T; Xiong Y; Wildt KF; Zhu J; Feigenbaum L; Bendelac A; Bosselut R
    Eur J Immunol; 2010 Sep; 40(9):2385-90. PubMed ID: 20706986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of autoreactive T cells associated with murine collagen-induced arthritis using peptide-MHC multimers.
    Huang JC; Vestberg M; Minguela A; Holmdahl R; Ward ES
    Int Immunol; 2004 Feb; 16(2):283-93. PubMed ID: 14734614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ex vivo induction and expansion of natural killer T cells by CD1d1-Ig coated artificial antigen presenting cells.
    Webb TJ; Bieler JG; Schneck JP; Oelke M
    J Immunol Methods; 2009 Jul; 346(1-2):38-44. PubMed ID: 19446558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.